Amendment No. 3 to Research Subaward Agreement between Yale University and Miragen Therapeutics, Inc.
Yale University and Miragen Therapeutics, Inc. have amended their research subaward agreement for a project funded by the National Heart, Lung, and Blood Institute. This amendment extends the project period through June 30, 2017, sets the budget period from August 19, 2016 to June 30, 2017, and authorizes funding for this period. It also allows pre-award spending from July 1, 2016 to August 18, 2016. All other terms of the original agreement remain unchanged.
Exhibit 10.14
[*] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended.
| Research Subaward Agreement Amendment | ||||||
|
Pass-through Entity (PTE)
|
Subrecipient
| |||||
| PTE: Yale University | Subrecipient: Miragen Therapeutics, Inc.
| |||||
| Address: Office of Sponsored Projects 25 Science Park – 3rd Floor 150 Munson Street P.O. Box 208327 | Address: 6200 Lookout Road | |||||
| City, State, Zip+4 (Country): New Haven, CT ###-###-####
| City, State, Zip+4 (Country): Boulder, CO 80301
| |||||
| PTE Principal Investigator (PI): [*], MD
| Subrecipient Principal Investigator (PI): Rusty Montgomery, MD | |||||
| PTE Federal Award No: 4UH2HL123886-03 REVISED | FAIN: UH2HL123886 | Federal Awarding Agency: National Heart, Lung, and Blood Institute |
| Project Title: Mir-29 mimicry as a therapy for pulmonary fibrosis
| ||||||
| Subaward Period of Performance: Start Date: 8/19/2016 End Date: 6/30/2017
| Amount Funded This Action: [*] | Amendment No: 3 | Subaward No: M15A12064 (A10747) | |||
| Effective Date of Amendment: 10/27/2016
| FFATA Reporting: Y | |||||
|
Amendment(s) to Original Terms and Conditions This Amendment revises the above-referenced Research Subaward Agreement as follows:
| ||||||
|
● Subaward Period of Performance is extended through June 30, 2017.
● Budget Period is August 19, 2016 to June 30, 2017.
● Authorized Funding for Budget Period is [*].
● Pre-award is authorized for July 1, 2016 to August 18, 2016.
| ||||||
| All other terms and conditions of this Subaward Agreement remain in full force and effect. | ||||||
| By an Authorized Official of Pass-through Entity: | By an Authorized Official of Subrecipient: | |||||||||||
| /s/[*] | [*] | /s/ Jason A. Leverone | 1/23/17 | |||||||||
|
Name: [*] |
Date |
Name: Jason A. Leverone |
Date | |||||||||
| Title: Award Manager
| Title: CFO | |||||||||||
